Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jun;105(12):4931-4941.
doi: 10.1007/s00253-021-11389-6. Epub 2021 Jun 18.

Plague vaccines: new developments in an ongoing search

Affiliations
Review

Plague vaccines: new developments in an ongoing search

Jason A Rosenzweig et al. Appl Microbiol Biotechnol. 2021 Jun.

Abstract

As the reality of pandemic threats challenges humanity, exemplified during the ongoing SARS-CoV-2 infections, the development of vaccines targeting these etiological agents of disease has become increasingly critical. Of paramount concern are novel and reemerging pathogens that could trigger such events, including the plague bacterium Yersinia pestis. Y. pestis is responsible for more human deaths than any other known pathogen and exists globally in endemic regions of the world, including the four corners region and Northern California in the USA. Recent cases have been scattered throughout the world, including China and the USA, with serious outbreaks in Madagascar during 2008, 2013-2014, and, most recently, 2017-2018. This review will focus on recent advances in plague vaccine development, a seemingly necessary endeavor, as there is no Food and Drug Administration-licensed vaccine available for human distribution in western nations, and that antibiotic-resistant strains are recovered clinically or intentionally developed. Progress and recent development involving subunit, live-attenuated, and nucleic acid-based plague vaccine candidates will be discussed in this review. KEY POINTS: • Plague vaccine development remains elusive yet critical. • DNA, animal, and live-attenuated vaccine candidates gain traction.

Keywords: DNA vaccines; Humoral; Live attenuated; Protection; Protein subunit.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Similar articles

Cited by

References

    1. Abbott RC, Russell RE, Richgels KLD, Tripp DW, Matchett MR, Biggins DE, Rocke TE. Factors influencing uptake of sylvatic plague vaccine baits by prairie dogs. Ecohealth. 2018;15(1):12–22. doi: 10.1007/s10393-017-1294-1. - DOI - PubMed
    1. Abby SS, Rocha EP. The non-flagellar type III secretion system evolved from the bacterial flagellum and diversified into host-cell adapted systems. PLoS Genet. 2012;8(9):e1002983. doi: 10.1371/journal.pgen.1002983. - DOI - PMC - PubMed
    1. Achtman M, Zurth K, Morelli G, Torrea G, Guiyoule A, Carniel E. Yersinia pestis, the cause of plague, is a recently emerged clone of Yersinia pseudotuberculosis. Proc Natl Acad Sci U S A. 1999;96:14043–14048. doi: 10.1073/pnas.96.24.14043. - DOI - PMC - PubMed
    1. Albrecht MT, Livingston BD, Pesce JT, Bell MG, Hannaman D, Keane-Myers AM. Electroporation of a multivalent DNA vaccine cocktail elicits a protective immune response against anthrax and plague. Vaccine. 2012;30(32):4872–4883. doi: 10.1016/j.vaccine.2012.04.078. - DOI - PubMed
    1. Albrecht MT, Eyles JE, Baillie LW, Keane-Myers AM. Immunogenicity and efficacy of an anthrax/plague DNA fusion vaccine in a mouse model. FEMS Immunol Med Microbiol. 2012;65(3):505–509. doi: 10.1111/j.1574-695X.2012.00974.x. - DOI - PubMed